BioSpace News Archive

Recognition honors companies that take the long view with a purpose-based strategy and strive to create positive change throughout their global communities

Analysis by Vizient, Inc. of four drugs that have been consistently used in hospitals in some cases for more than 50 years, shows manufacturers are choosing to take significant price increases after receiving formal approval by the Food and Drug Administration.

A new paper published in Nature Communications introduces VIRGO, the first comprehensive non-redundant gene catalog of the human vaginal microbiome.

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full-year ended December 31, 2019.

Investigational medicine TAK-062 is an oral computationally engineered super glutenase designed to improve the digestion of gluten

Optoelectronic technologies benefit our daily lives from every aspect. However less people know that optoelectronic technologies are playing a key role amid the fight against COVID-19, especially for technologies such as information and communication, infrared, precision optics, optoelectronic sensor, etc.

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the Raymond James 41st Annual Institutional Investors Conference.

Endo International plc (NASDAQ: ENDP) today reported financial results for the fourth quarter and full year ended December 31, 2019.

BioMarin Pharmaceutical Inc. announced financial results for the fourth quarter and full year 2019.

NanoString Technologies, Inc., a leading provider of life science tools for translational research, reported financial results for the fourth quarter and year ended December 31, 2019.